tiprankstipranks
Trending News
More News >

Compumedics Secures FDA Clearance for Falcon™ HST, Targeting US Market Growth

Story Highlights
Compumedics Secures FDA Clearance for Falcon™ HST, Targeting US Market Growth

Confident Investing Starts Here:

Compumedics Limited ( (AU:CMP) ) has issued an announcement.

Compumedics Limited has received FDA clearance to market its Falcon™ HST device in the USA, marking a significant milestone in its strategy to expand within the fast-growing home sleep testing (HST) market. The company aims to capture 10% to 30% of the USD100m-200m addressable market over the next 24 months, leveraging its success in Australia and its established sales team in the USA. The Falcon™ HST offers a clinically advanced, scalable technology that enhances patient convenience and reduces costs, positioning Compumedics to capitalize on the high-growth potential of the US market.

More about Compumedics Limited

Compumedics Limited is a global medical device company that develops, manufactures, and commercializes diagnostic technology for sleep, brain, and ultrasonic blood flow monitoring.

Average Trading Volume: 60,066

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: A$49.98M

See more insights into CMP stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App